Nieoczekiwane rozpoznanie ustalone u chorego z napadem migotania przedsionków Opis przypadku
##plugins.themes.bootstrap3.article.main##
Abstrakt
Prezentujemy przypadek 52-letniego pacjenta z kardiomiopatią restrykcyjną oraz z wywiadem napadowego migotania przedsionków, u którego w toku szczegółowej diagnostyki wysunięto podejrzenie choroby łańcuchów lekkich jako potencjalnej przyczyny przerostu mięśnia lewej komory.
Pobrania
##plugins.themes.bootstrap3.article.details##
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
Bibliografia
2. Buxbaum JN, Chuba JV, Hellman GC et al. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis: clinical features, immunopathology, and molecular analysis. Ann Intern Med 1990; 112(6): 455-464.
3. Fabbian F, Stabellini N, Sartori S et al. Light chain deposition disease presenting as paroxysmal atrial fibrillation: a case report. J Med Case Rep 2007; 1: 187.
4. Koopman P, Van Dorpe J, Maes B, Dujardin K. Light chain deposition disease as a rare cause of restrictive cardiomyopathy. Acta Cardiol 2009; 64(6): 821-824.
5. Chugh SS, Blackshear JL, Shen WK et al. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 2001; 37(2): 371-378.
6. Benjamin EJ, Wolf PA, D’Agostino RB et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98(10): 946-952.
7. Williams LK, Frenneaux MP, Steeds RP. Echocardiography in hypertrophic cardiomyopathy diagnosis, prognosis, and role in management. Eur J Echocardiogr 2009; 10(8): iii9-14.
8. Kushwaha SS, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med 1997; 336(4): 267-276.
9. Seward JB, Casaclang-Verzosa G. Infiltrative cardiovascular diseases: cardiomyopathies that look alike. J Am Coll Cardiol 2010; 55(17): 1769-1779.
10. Pozzi C, Locatelli F. The patient with insidious chronic renal failure and the patient with the nephrotic syndrome – two manifestations of a protean and not so rare disease. Nephrol Dial Transplant 1996; 11(9): 1876-1880.